Barclays raised the firm’s price target on Emerson (EMR) to $116 from $103 and keeps an Equal Weight rating on the shares post the fiscal Q4 report. The shares could see a positive reaction with the Aspen Technology (AZPN) deal soon to be out of the way, an in-line Q1 guide, and amid negative investor positioning, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMR:
- Emerson Electric Reports Strong 2024 Financial Results
- Aspen Technology confirms receipt of unsolicited takeover proposal from Emerson
- Emerson price target raised to $140 from $136 at Deutsche Bank
- Boeing union to end strike, Palantir reports Q3 beat: Morning Buzz
- Early notable gainers among liquid option names on November 5th